Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALISKIREN HEMIFUMARATE Cause Muscle spasticity? 181 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 181 reports of Muscle spasticity have been filed in association with ALISKIREN HEMIFUMARATE (Aliskiren). This represents 35.8% of all adverse event reports for ALISKIREN HEMIFUMARATE.

181
Reports of Muscle spasticity with ALISKIREN HEMIFUMARATE
35.8%
of all ALISKIREN HEMIFUMARATE reports
0
Deaths
176
Hospitalizations

How Dangerous Is Muscle spasticity From ALISKIREN HEMIFUMARATE?

Of the 181 reports, 176 (97.2%) required hospitalization, and 166 (91.7%) were considered life-threatening.

Is Muscle spasticity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALISKIREN HEMIFUMARATE. However, 181 reports have been filed with the FAERS database.

What Other Side Effects Does ALISKIREN HEMIFUMARATE Cause?

Nausea (227) Fall (214) Cerebrovascular accident (196) Anxiety (195) Fatigue (186) Confusional state (185) Muscular weakness (184) Hemiparesis (181) Hemiplegia (181) Personality disorder (181)

What Other Drugs Cause Muscle spasticity?

BACLOFEN (2,893) METHOTREXATE (829) ACETAMINOPHEN (745) TOCILIZUMAB (646) ABATACEPT (628) LEFLUNOMIDE (617) OCRELIZUMAB (610) CERTOLIZUMAB PEGOL (607) GOLIMUMAB (607) ETANERCEPT (606)

Which ALISKIREN HEMIFUMARATE Alternatives Have Lower Muscle spasticity Risk?

ALISKIREN HEMIFUMARATE vs ALISKIREN\HYDROCHLOROTHIAZIDE ALISKIREN HEMIFUMARATE vs ALIZAPRIDE ALISKIREN HEMIFUMARATE vs ALLANTOIN ALISKIREN HEMIFUMARATE vs ALLEGRA ALISKIREN HEMIFUMARATE vs ALLEGRA 24 HOUR

Related Pages

ALISKIREN HEMIFUMARATE Full Profile All Muscle spasticity Reports All Drugs Causing Muscle spasticity ALISKIREN HEMIFUMARATE Demographics